Colin J. Sallee

Colin J. Sallee

Auto-generated profile, based on publicly available information

Colin J. Sallee

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of California Los Angeles, Los Angeles, CA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2023 in Journal of Intensive Care Medicine
Verified
Journal Article
Open access
CSColin J. Sallee
Colin J. Sallee
JHJoseph A. Hippensteel
Joseph A. Hippensteel
KMKristen R. Miller
Kristen R. Miller
KOKaori Oshima
Kaori Oshima
APAndrew T. Pham
Andrew T. Pham
AMAline B. Maddux
Aline B. Maddux
Background: Sepsis-associated destruction of the pulmonary microvascular endothelial glycocalyx (EGCX) creates a vulnerable endothelial surface, contributing to the development of acute respiratory distress syndrome (ARDS). Constituents of the EGCX shed into circulation, glycosaminoglycans and proteoglycans, may serve as biomarkers of endothelial dysfunction. We sought to define the patterns of plasma EGCX degradation products in children with sepsis-associated pediatric ARDS (PARDS), and test their association with clinical outcomes. Methods: We retrospectively analyzed a prospective cohort (2018-2020) of children (≥1 month to 60% of the severe PARDS patients (test for trend, p = 0.04). Higher total heparan sulfate and N-sulfated disaccharide levels were independently associated with fewer 28-day ventilator-free days in children with sepsis-associated PARDS (all p < 0.05). Conclusions: Children with sepsis-associated PARDS exhibited higher plasma levels of heparan sulfate disaccharides and syndecan-1, suggesting that EGCX degradation biomarkers may provide insights into endothelial dysfunction and PARDS pathobiology.

20 July 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
CSColin J. Sallee
Colin J. Sallee
LSLincoln S. Smith
Lincoln S. Smith
CRCourtney M. Rowan
Courtney M. Rowan
SHSusan R. Heckbert
Susan R. Heckbert
JAJoseph R. Angelo
Joseph R. Angelo
JFJulie C. Fitzgerald
Julie C. Fitzgerald
Objectives: To evaluate the associations between early cumulative fluid balance (CFB) and outcomes among critically ill pediatric allogeneic hematopoietic cell transplant (HCT) recipients with acute respiratory failure, and determine if these associations vary by treatment with renal replacement therapy (RRT).Methods: We performed a secondary analysis of a multicenter retrospective cohort of patients (1mo - 21yrs) post-allogeneic HCT with acute respiratory failure treated with invasive mechanical ventilation (IMV) from 2009 to 2014. Fluid intake and output were measured daily for the first week of IMV (day 0 = day of intubation). The exposure, day 3 CFB (CFB from day 0 through day 3 of IMV), was calculated using the equation [Fluid in – Fluid out] (liters)/[PICU admission weight](kg)*100. We measured the association between day 3 CFB and PICU mortality with logistic regression, and the rate of extubation at 28 and 60 days with competing risk regression (PICU mortality = competing risk).Results: 198 patients were included in the study. Mean % CFB for the cohort was positive on day 0 of IMV, and increased further on days 1-7 of IMV. For each 1% increase in day 3 CFB, the odds of PICU mortality were 3% higher (adjusted odds ratio (aOR) 1.03, 95% CI 1.00-1.07), and the rate of extubation was 3% lower at 28 days (adjusted subdistribution hazard ratio (aSHR) 0.97, 95% CI 0.95-0.98) and 3% lower at 60 days (aSHR 0.97, 95% CI 0.95-0.98). When day 3 CFB was dichotomized, 161 (81%) had positive and 37 (19%) had negative day 3 CFB. Positive day 3 CFB was associated with higher PICU mortality (aOR 3.42, 95% CI 1.48-7.87) and a lower rate of extubation at 28 days (aSHR 0.30, 95% CI 0.18-0.48) and 60 days (aSHR 0.30, 95% 0.19-0.48). On stratified analysis, the association between positive day 3 CFB and PICU mortality was significantly stronger in those not treated with RRT (no RRT: aOR 9.11, 95% CI 2.29-36.22; RRT: aOR 1.40, 95% CI 0.42-4.74).Conclusions: Among critically ill pediatric allogeneic HCT recipients with acute respiratory failure, positive and increasing early CFB were independently associated with adverse outcomes.

1 October 2024 in Shock
Verified
Journal Article
Closed access
CSColin J. Sallee
Colin J. Sallee
AMAline B. Maddux
Aline B. Maddux
JHJoseph A. Hippensteel
Joseph A. Hippensteel
DMDaniela Markovic
Daniela Markovic
KOKaori Oshima
Kaori Oshima
ASAnil Sapru
Anil Sapru
Introduction: Sepsis-induced degradation of endothelial glycocalyx heparan sulfate (HS) contributes to the pulmonary microvascular endothelial injury characteristic of acute respiratory distress syndrome (ARDS) pathogenesis. Our objectives were to (1) examine relationships between plasma indices of HS degradation and protein biomarkers of endothelial injury and (2) identify patient subgroups characterized by distinct profiles of HS degradation in children with ARDS. Methods: We analyzed prospectively collected plasma (2018–2020) from a cohort of invasively mechanically ventilated children (aged >1 month to <18 years) with ARDS. Mass spectrometry characterized and quantified patterns of HS disaccharide sulfation. Protein biomarkers reflective of endothelial injury (e.g., angiopoietin-2, vascular cell adhesion molecule-1, soluble thrombomodulin) were measured with a multiplex immunoassay. Pearson correlation coefficients were used to construct a biomarker correlation network. Centrality metrics detected influential biomarkers (i.e., network hubs). K-means clustering identified unique patient subgroups based on HS disaccharide profiles. Results: We evaluated 36 patients with pediatric ARDS. HS disaccharide sulfation patterns, 6S, NS, and NS2S, positively correlated with all biomarkers of endothelial injury (all P < 0.05) and were classified as network hubs. We identified three patient subgroups, with cluster 3 (n = 5) demonstrating elevated levels of 6S and N-sulfated HS disaccharides. In cluster 3, 60% of children were female and nonpulmonary sepsis accounted for 60% of cases. Relative to cluster 1 (n = 12), cluster 3 was associated with higher oxygen saturation index (P = 0.029) and fewer 28-day ventilator-free days (P = 0.016). Conclusions: Circulating highly sulfated HS fragments may represent emerging mechanistic biomarkers of endothelial injury and disease severity in pediatric ARDS.

11 October 2022 in Journal of Pediatric Intensive Care
Verified
Journal Article
Closed access
PDF file
CSColin J. Sallee
Colin J. Sallee
JFJulie C. Fitzgerald
Julie C. Fitzgerald
LSLincoln S. Smith
Lincoln S. Smith
JAJoseph R. Angelo
Joseph R. Angelo
MDMegan C. Daniel
Megan C. Daniel
ONon behalf of the Pediatric Acute Lung Injury Sepsis Investigators (PALISI) Network
on behalf of the Pediatric Acute Lung Injury Sepsis Investigators (PALISI) Network
The aim of the study is to examine the relationship between fluid overload (FO) and severity of respiratory dysfunction in children post-hematopoietic cell transplantation (HCT) with pediatric acute respiratory distress syndrome (PARDS). This investigation was a secondary analysis of a multicenter retrospective cohort of children (1month to 21 years) post-allogeneic HCT with PARDS receiving invasive mechanical ventilation (IMV) from 2009 to 2014. Daily FO % (FO%) and daily oxygenation index (OI) were calculated for each patient up to the first week of IMV (day 0 = intubation). Linear mixed-effect regression was employed to examine whether FO% and OI were associated on any day during the study period. In total, 158 patients were included. Severe PARDS represented 63% of the cohort and had higher mortality (78 vs. 42%, p <0.001), fewer ventilator free days at 28 (0 [IQR 0–0] vs. 14 [IQR 0–23], p <0.001), and 60 days (0 [IQR 0–27] v. 45 [IQR 0–55], p <0.001) relative to non-severe PARDS. Increasing FO% was strongly associated with higher OI (p <0.001). For children with 10% FO, OI was higher by nearly 5 points (adjusted β 4.6, 95% CI [2.9, 6.3]). In subgroup analyses, the association between FO% and OI was strongest among severe PARDS (p <0.001) and during the first 3 days elapsed from intubation (p <0.001). FO% was associated with lower PaO2/FiO2 (adjusted β −1.92, 95% CI [−3.11, −0.73], p = 0.002), but not mean airway pressure (p = 0.746). In a multicenter cohort of children post-HCT with PARDS, FO was independently associated with oxygenation impairment. The associations were strongest among children with severe PARDS and early in the course of IMV. Received: 13 March 2022 Accepted: 23 August 2022 Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

7 September 2026 in Critical Care Medicine
Verified
Journal Article
Closed access
CSColin J. Sallee
Colin J. Sallee
CTClove S. Taylor
Clove S. Taylor
MZMatt S. Zinter
Matt S. Zinter
DMDaniela Markovic
Daniela Markovic
MLMichelle J. Lim
Michelle J. Lim
ASAnil Sapru
Anil Sapru
OBJECTIVES: Molecular subphenotypes, identified through latent class analysis (LCA) of biomarker profiles, have the potential to guide targeted therapeutics in critical care. We have previously published that intensive insulin management has subphenotype-specific beneficial effects among children with hyperglycemia accompanying cardiorespiratory failure. However, the real-time application of subphenotype-based strategies in clinical settings remains challenging due to the operational aspects of biomarker assays. Our study had three objectives: 1) to compare biomarker measurements from rapid immunoassay and conventional multiplex platforms; 2) to evaluate the cross-platform transportability of a conventional assay-based parsimonious classifier for LCA-derived subphenotypes and compare it with a classifier trained directly on rapid immunoassay data; and 3) to assess the prognostic and predictive significance of rapid immunoassay-based subphenotypes. DESIGN: Retrospective cohort study. SETTING: Multicenter PICUs. PATIENTS: Two hundred sixty-nine critically ill children with acute cardiorespiratory failure and hyperglycemia (2012–2016). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: LCA was previously used to derive hyperinflammatory and hypoinflammatory classes using a conventional multiplex assay of 13 plasma biomarkers. After feature selection, a parsimonious classifier using interleukin (IL)-6, IL-8, and soluble tumor necrosis factor receptor 1 (sTNFR-1) was developed to predict LCA-derived subphenotypes. We applied this classifier to rapid immunoassay biomarker measurements, yielding an area under the receiver operating characteristic curve (AUROC) of 0.90 (95% CI, 0.85–0.95). However, calibration was poor due to systematic underestimation of sTNFR-1 concentrations by the rapid platform. We then derived and internally validated via bootstrapping a de novo classifier using rapid immunoassay data, achieving an AUROC of 0.90 (95% CI, 0.86–0.95) and excellent calibration. Using a probability threshold of ≥ 0.5, the de novo classifier matched LCA-derived classifications in 241 of 269 cases (accuracy 89.6%). Rapid immunoassay-based subphenotypes demonstrated differences in mortality (33.3% in hyperinflammatory vs. 11.8% in hypoinflammatory; p = 0.009) and differential response to intensive insulin management (interaction p = 0.024). CONCLUSIONS: A parsimonious, rapid immunoassay-based classifier can approximate LCA-derived molecular subphenotypes while preserving their prognostic and predictive significance, with the potential to inform future subphenotype-based precision trials.

26 June 2026 in Scientific Reports
Verified
Journal Article
Open access
CSColin J. Sallee
Colin J. Sallee
AMAline B. Maddux
Aline B. Maddux
JHJoseph A. Hippensteel
Joseph A. Hippensteel
DMDaniela Markovic
Daniela Markovic
ZWZhangjie Wang
Zhangjie Wang
ASAnil Sapru
Anil Sapru
Endothelial glycocalyx (eGCX) shedding contributes to microvascular endotheliopathy in Acute Respiratory Distress Syndrome (ARDS) and may represent an underrecognized source of phenotypic heterogeneity. We examined whether circulating heparan sulfate (HS) signatures, as readouts of eGCX shedding, capture patterns of inter-patient biological variation distinct from other eGCX components and conventional protein biomarkers, whether specific HS structural features are enriched, and whether these signatures are associated with heparanase-1 (HPSE) activity. We retrospectively analyzed prospectively collected plasma samples (2018–2020) from children with and without pediatric ARDS (PARDS). Plasma levels (ng/mL) of sulfated and non-sulfated HS disaccharides (following enzymatic digestion of total [unfractionated] HS), and HPSE activity (U/mL) were measured using mass spectrometry, while protein biomarkers were assessed by multiplex assay. Among 46 children (36 PARDS, 10 no PARDS), principal component analysis identified three components explaining > 60% of the variance. The primary component (PC1) was characterized by an HS-driven endothelial signature and was distinct from an inflammatory protein signature captured by PC2. In PARDS, children with higher PC1 scores had worse organ dysfunction and fewer ventilator-free days after adjustment for PC2 and PC3. Higher total HS levels were further associated with selective enrichment of sulfated HS motifs, whereas the opposite pattern was observed in non-PARDS. HPSE activity positively correlated with circulating HS levels. These preliminary findings suggest that circulating HS signatures capture a distinct and clinically meaningful dimension of PARDS heterogeneity.